## Abstract Head and neck squamous cell carcinomas (HNSCCs) remain a significant cause of morbidity worldwide. Biological therapies able to induce and/or upregulate antitumor immune responses could represent a complementary approach to conventional treatments for patients with HNSCC because, despit
Loss of adhesion/growth-regulatory galectin-9 from squamous cell epithelium in head and neck carcinomas
✍ Scribed by Zdeněk Fík; Jaroslav Valach; Martin Chovanec; Jiří Mazánek; Roman Kodet; Ondřej Kodet; Ruth Tachezy; Eva Foltynová; Sabine André; Herbert Kaltner; Hans-Joachim Gabius; Karel Smetana Jr
- Book ID
- 114797277
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 966 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0904-2512
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background. Loss of heterozygosity (LOH) studies have been pivotal in identifying tumor suppressor genes involved in the pathogenesis of a number of cancers. In squamous cell carcinomas of the head and neck region (SCCHN), LOH studies using the Southern blot technique are scarce. Methods. SCCHNs we
## Abstract ## Background __IGF2__ and __H19__ are reciprocal imprinted genes with paternal and maternal monoallelic expression, respectively. This is interesting, because __IGF2__ is known as a growth factor, and __H19__ encodes a RNA with putative tumor suppressor action. Furthermore, __IGF2__ a
## Abstract ## Background. __ZAC/Lot1__ is a previously identified candidate tumor suppressor gene. The gene maps to the human chromosome 6q24‐q25, a region frequently deleted in squamous cell carcinomas of the head and neck and other solid tumors. ## Methods. We have used a model of head and ne